Treatment options for hyperthyroidism

Hospital Practice

Volumn 31, Issue 9, 1996, Pages 69-83

  Wartofsky, Leonard ^a,b,c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

AGRANULOCYTOSIS; CLINICAL PROTOCOL; DRUG EFFICACY; GRAVES DISEASE; HUMAN; HYPERTHYROXINEMIA; PRURITUS; RADIOISOTOPE THERAPY; RASH; REVIEW; THYROID ADENOMA; THYROIDECTOMY; TOXIC GOITER; TREATMENT OUTCOME;

EID: 0009059471     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1996.11443345     Document Type: Review

References (6)

1. Benker G et al: Response to methimazole in Graves' disease: The European Multicenter Study Group. Clin Endocrinol 43:257, 1995
2. Burch HB, Wartofsky L: Hyperthyroldism. In Current Therapy In Endocrinology and Metabolism, 5th ed, Bardin CW (Ed), B. C. Decker, Philadelphia; Mosby, St. Louis, 1994, pp 64-70
3. Levetan C, Wartofsky L: A clinical guide to the management of Graves' disease with radioactive iodine. Endocrine Pract 1:205, 1995
4. Peele ME, Wartofsky L: A rational approach to the treatment of hyperthyroidism. Compr Ther 14:34, 1988
5. Solomon B et al: Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70:1518, 1990
6. Tallstedt L et al: Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism: The Thyroid Study Group. N Engl J Med 326: 1733, 1992